• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G125
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Unspecified Infection (1930); Staphylococcus Aureus (2058); Fluid Discharge (2686); No Code Available (3191)
Event Date 04/13/2020
Event Type  Death  
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.(b)(4).
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to infection.Reportedly, the patient was presenting with one week of bloody, non-purulent discharge and 1-2 cm defect in skin overlying the pacemaker.Initially, there was concern for right ventricular (rv) lead mass, however no valvular or lead vegetation was noted.Moreover, the patient had methicillin-resistant staphylococcus aureus (mrsa) infection.The patient was treated with intravenous antibiotics.There were no additional adverse patient effects reported.The crt-d was explanted.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery and the additional intervention treatment with the use of intravenous antibiotics.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) was explanted due to infection.Following treatment with intravenous antibiotics, the patient was afebrile, hemodynamically stable, without leukocytosis, and without signs of systemic infection.No vegetation was found on the right ventricular lead.The right ventricular (rv) lead, right atrial (ra) lead and left ventricular (lv) lead were surgically abandoned due to high risk of lead extraction.Wound cultures showed methicillin-resistant staphylococcus aureus (mrsa).Additional information was received indicating that the patient had expired approximately three months following the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10639802
MDR Text Key210155523
Report Number2124215-2020-19898
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589126
UDI-Public00802526589126
Combination Product (y/n)N
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/27/2021
Device Model NumberG125
Device Catalogue NumberG125
Device Lot Number135953
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/27/2020
Date Manufacturer Received10/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age93 YR
Patient Weight68
-
-